Search
Now showing items 1-5 of 5
Frequency of genetic polymorphism for adrenergic receptor beta and cytochrome p450 2D6 enzyme, and effects on tolerability of beta-blocker therapy in heart failure with reduced ejection fraction patients: The Beta GenTURK study
(TURKISH SOC CARDIOLOGY, 2016)
Objective: The present objective was to determine frequency of Arginine389Glycine (Arg389Gly) and Cytochrome p450 2D6*10 (Cyp2D6*10) polymorphism in cases of heart failure-reduced ejection fraction (HFREF), and to evaluate ...
Practical approaches for the treatment of chronic heart failure: Frequently asked questions, overlooked points and controversial issues in current clinical practice
(TURKISH SOC CARDIOLOGY, 2015)
Heart failure (HF) is a progressive disorder associated with impaired quality of life, high morbidity, mortality and frequent hospitalization and affects millions of people from all around the world. Despite further ...
Relationship between functional capacity and socioeconomic status in a cohort of Turkish heart failure patients
(TURKISH SOC CARDIOLOGY, 2016)
Objective: New York Heart Association (NYHA) classification predicts prognosis for heart failure (HF) patients. Socioeconomic status (SES) has the potential to affect treatment strategy and disease course. The present ...
Diagnosis and management of acute heart failure
(TURKISH SOC CARDIOLOGY, 2015)
Acute heart failure (AHF) is a life threatening clinical syndrome with a progressively increasing incidence in general population. Turkey is a country with a high cardiovascular mortality and recent national statistics ...
Lymphocytopenia is associated with poor NYHA functional class in chronic heart failure patients with reduced ejection fraction
(TURKISH SOC CARDIOLOGY, 2015)
Objective: In heart failure (HF) patients, functional capacity has been demonstrated to be a marker of poor prognosis, independent of left ventricular ejection fraction (EF). Lymphocyte count is currently recognized in ...